Is ABOS or ABVC more undervalued in 2026?

CirclFi compares Acumen Pharmaceuticals, Inc. (ABOS) and ABVC Biopharma, Inc. (ABVC) using 13 institutional-grade valuation models. ABOS has a Quality of Company score of 4.3/10 while ABVC scores 4.9/10.

Which is a better buy — ABOS or ABVC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ABOS and ABVC valuations compare?

ABOS at $2.60 and ABVC at $1.41 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ABOS vs ABVC Valuation Comparison 2026 — Intrinsic Value Analysis

ABOS

Biotechnology

Acumen Pharmaceuticals, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$2.60

Last close

Models

7/13

Active

ABVC

Biotechnology

ABVC Biopharma, Inc.

Quality

4.9

out of 10

Value Trap

SAFE

Price

$1.41

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	ABOS Fair Value	ABOS Upside	ABVC Fair Value	ABVC Upside
Bayesian DCF	Intrinsic	$0.92	-64.7%	$0.31	-78.3%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$1.71	-34.4%	$0.02	-98.4%
Dynamic NAV	Asset-Based	$1.90	-27.0%	$0.08	-94.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ABOS vs ABVC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ABOS vs ABVC — Which Stock Is More Undervalued?

ABVC scores higher with a 4.9/10 quality rating vs ABOS's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Acumen Pharmaceuticals, Inc. (ABOS) and ABVC Biopharma, Inc. (ABVC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ABOS currently trades at $2.60 with a QOC of 4.3/10, while ABVC trades at $1.41 with a QOC of 4.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).